Concepedia

Philip D. Hansten

PD

Statistics

Publications

26

Citations

2.7K

H-Index

19

Active since

1979

Affiliations

University of Washington(Current)

University of Arizona

Fred Hutch Cancer Center

University of Pittsburgh

Albert Einstein College of Medicine

Philip D. Hansten is an author at University of Washington specializing in pharmacology, drug interactions, and clinical pharmacology.

ORCID

Publications per year

1979–2023

26

Publications

26

Proposal for a New Tool to Evaluate Drug Interaction Cases

John R. Horn, Philip D. Hansten, Lingtak‐Neander Chan · Annals of Pharmacotherapy · 2007 · 577 citations

, , +17

Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.

Diana C. Farrow, Thomas L. Vaughan, Philip D. Hansten et al. · PubMed · 1998 · 417 citations

, , +13

Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer

Diana C. Farrow, Thomas L. Vaughan, Carol Sweeney et al. · Cancer Causes & Control · 2000 · 228 citations

, , +16

Concordance of Severity Ratings Provided in Four Drug Interaction Compendia

Jacob Abarca, Daniel C. Malone, Edward P. Armstrong et al. · Journal of the American Pharmacists Association · 2004 · 208 citations

, , +13

Identification of Serious Drug–Drug Interactions: Results of the Partnership to Prevent Drug–Drug Interactions

Daniel C. Malone, Edward P. Armstrong, Jacob Abarca et al. · Journal of the American Pharmacists Association · 2004 · 191 citations

, , +14

1–5 of 26